Skip to content

Category: Patient resources

Explore our medication guides and pharmacology articles within this category.

How much does Trikafta cost for cystic fibrosis patients?

4 min read
The annual list price for the cystic fibrosis medication Trikafta can exceed $300,000, but this figure does not reflect what most patients actually pay out-of-pocket. Understanding **how much does Trikafta cost for cystic fibrosis patients** is crucial, as the final expense is influenced heavily by insurance coverage and financial assistance programs.

Do you have to pay for epilepsy medication? Navigating costs and financial assistance

4 min read
While the quality of epilepsy treatments has dramatically improved, the cost of newer, brand-name anti-seizure medications has also significantly increased, making cost a major concern for many patients. So, do you have to pay for epilepsy medication? The short answer is yes, in most cases, but the exact amount depends on several factors, and there are numerous programs to help reduce the financial burden.

What is the Price of Firazyr and How to Manage the High Cost?

4 min read
According to reports, the list price for a carton of brand-name Firazyr can exceed $33,000 without insurance, making it a significantly expensive medication. However, this high **price of Firazyr** is not what most patients pay, as the final cost is heavily influenced by factors like insurance coverage, patient assistance programs, and the availability of generic alternatives.

How do I get tepezza? Your Complete Guide to the Treatment Process

5 min read
According to a 2022 review, teprotumumab (Tepezza) was shown to significantly improve symptoms like eye bulging and double vision for patients with Thyroid Eye Disease (TED). If you are seeking this treatment, understanding **how do I get tepezza?** requires navigating a specific and often complex multi-step process involving your doctor, your insurance, and the manufacturer's support system.

How Much Does Revlimid Cost Without Insurance?

3 min read
Revlimid (lenalidomide), a crucial medication used in the treatment of various blood and bone marrow cancers, is known for its high cost. In 2021 alone, it accounted for over **$5.8 billion** in Medicare Part D spending, highlighting the financial burden associated with this drug. For individuals without insurance, understanding how much Revlimid costs without insurance is essential to navigating treatment.

Understanding: How much is acetazolamide 250mg?

5 min read
The average retail price for Acetazolamide 250mg can exceed $120 for 60 tablets, but many patients pay significantly less using coupons or insurance. This variation highlights the importance of understanding how to navigate the complex pharmaceutical market when asking: **How much is acetazolamide 250mg?**

How Much Does Bimzelx Cost in the US? A Complete Guide to Pricing

4 min read
The list price for one 1mL autoinjector or syringe of Bimzelx is reported as high as $7,922.89 as of January 2025, but most patients will not pay this amount due to insurance and manufacturer programs. Understanding the different factors that influence your final out-of-pocket expenses is crucial when determining how much does Bimzelx cost in the US for your specific situation. This guide will break down the list price, the impact of insurance, and the numerous options available to help reduce the financial burden.

How much does Vyndamax cost? Decoding the High Price and Savings

4 min read
The wholesale acquisition cost (WAC) for a 30-day supply of Vyndamax was over $22,000 as of January 2025. While this list price for the vital medication is exceptionally high, the actual out-of-pocket cost for patients depends heavily on their insurance, financial situation, and access to patient support programs.

Who is eligible for $35 Symbicort? A Guide to Affordability Programs

4 min read
According to the American Lung Association, millions of Americans rely on inhaled medications to manage conditions like asthma and COPD. To address the financial burden, pharmaceutical manufacturer AstraZeneca implemented a $35 monthly cap on out-of-pocket costs for its respiratory inhalers, prompting the question: who is eligible for $35 Symbicort?.